Journal of Antimicrobial Chemotherapy · 2010 · 71 citations · 23 references
Life SciencesInfectious DiseasesMolecular GeneticsMolecular VirologyPharmacogeneticsVirologyAntiretroviral TherapyHiv DiagnosisHiv TestingVariant InterpretationViral GeneticsViral TropismAmplificationAntiretroviral ResponseGenotypic ClassificationGenotypic IdentificationGold Standard AssessmentHigh-sensitivity AssaysViral Variant Detection
OBJECTIVES: Evaluation of the reliability of several V3-based genotypic predictors to infer viral tropism in patients infected with B and non-B strains of HIV-1. METHODS: Several genotypic tropism predictors were evaluated in plasma (RNA) samples from 198 HIV-1-infected patients, taking as gold standard the results of the phenotypic recombinant virus assay Phenoscript((R)). In addition, for 37 B subtype HIV-1 patients the phenotypic results from plasma samples were also compared with tropism predictions based on V3 amplification from paired peripheral blood mononuclear cells (PBMCs). RESULTS: A total of 150 paired genotypic/phenotypic results were obtained from plasma specimens. Concordance values ranged from 63% to 85%, depending on the genotypic algorithm used. The best predictors in terms of sensitivity/specificity to detect X4 variants were WebPSSM(X4/R5) (77%/87%), Geno2pheno(FPR) (=) (5%) (80%/77%) and an algorithm combining the '11/25' and 'Net charge' rules, termed Garrido's rule (80%/79%). The performance of genotypic predictors was better testing B than non-B clades. The overall sensitivity ranged from 28% to 94%, reaching 100% in subtype B antiretroviral-experienced patients using WebPSSM(SI/NSI), Geno2pheno(FPR) (> or =) (5%) and Garrido's rule. Conversely, the sensitivity when testing non-B subtypes was poorer, ranging from 17% to 67%. Interestingly, the correlation between genotypic and phenotypic results was better when testing PBMCs than plasma using all genotypic predictors. CONCLUSIONS: Genotypic tools based on V3 sequences may provide reliable information on HIV-1 tropism when testing clade B viruses, especially in antiretroviral-experienced patients. The sensitivity to detect X4 variants using genotypic tools may improve by testing proviral DNA instead of plasma RNA.
23
Identification of a major co-receptor for primary isolates of HIV-1
Hongkui Deng, Rong Liu, Wilfried Ellmeier et al. · Nature · 1996 · 3.7K citations
Patrick Dorr, Mike Westby, Susan Dobbs et al. · Antimicrobial Agents and Chemotherapy · 2005 · 1.1K citations
Identification of the Envelope V3 Loop as the Primary Determinant of Cell Tropism in HIV-1
Stephen S. Hwang, Terence J. Boyle, H. Kim Lyerly et al. · Science · 1991 · 864 citations
Mark A. Jensen, Fu-Sheng Li, Angélique B. van ’t Wout et al. · Journal of Virology · 2003 · 428 citations · Full text
Jeannette M. Whitcomb, Wei Huang, Signe Fransen et al. · Antimicrobial Agents and Chemotherapy · 2006 · 355 citations · Full text